On this week’s Found podcast, Darrell and Becca were joined by Trevor Martin, the co-founder and CEO of Mammoth Biosciences. Mammoth Biosciences is a startup that leverages CRISPR technology to diagnose and develop treatments for genetic diseases. Trevor shared his experiences regarding forming a tech-based enterprise with one of the inventors of CRISPR at the helm. Trevor discussed how this novel technology is capable of tackling a wide range of ailments, and the process the company went through selecting which problem to tackle first. Moreover, he spoke about Mammoth’s concern over public perception of their technology in an era where scientific research is often criticized.
Mammoth Biosciences is an early-stage biotech and healthcare diagnostics startup. Founded in 2018 by a group of CRISPR pioneers, the company applies cutting-edge technology to develop affordable, accurate and actionable diagnosis solutions. Using its proprietary CRISPR-based platform, Mammoth seeks to accurately identify and diagnose various diseases in just minutes. Its platform boasts high sensitivity and specificity for a range of conditions and pathogens, allowing for quick and efficient diagnosis and treatment programs.
Trevor Martin is a serial entrepreneur with experience in launching and leading biotech and healthcare companies. As the co-founder and CEO of Mammoth Biosciences, he leads the operations and activities of the company. Martin’s experience working in the industry combined with his background in biology and chemistry has enabled him to lead the team effectively. He believes that CRISPR offers a wealth of possibilities in the health industry, and hopes that Mammoth can leverage the cutting-edge technology to empower clinicians by providing accurate and informative medical solutions.
